Navigation Links
Biosimilars Market worth $1,954 Million by 2018
Date:11/18/2013

13 to 2018.

By application, oncology is the largest and fastest-growing segment and accounts for a share of 25% of the global Biosimilars Market. This is attributed to the increasing prevalence of oncology along with the rise in aging population and the changing lifestyle.

Europe dominates the global Biosimilars Market with around 40% share in 2013. The factors driving the European market are its well-defined regulatory guidelines; presence of various Biosimilar drugs such as omnitrope, tevagrastim, and binocrits; numerous pipeline products; and more than 15 biologics going off-patent in the coming years. Although the penetration of Biosimilars varies by country, it also depends on various other factors, including local pricing and reimbursement policies, stakeholder influence, and attitudes towards the adoption and use of Biosimilars. Currently, Germany commands the highest share in the European market due to the presence of a reference pricing system.

The U.S., on the other hand, has a very restricted Biosimilars Market owing to the stringent regulatory environment in North America. The Asia-Pacific market is estimated to be the fastest-growing market. Asia-Pacific accounts for an overall share of 29% of the global Biosimilars Market. This large share of the market is mainly due to the semi-regulatory environment of the region that easily approves similar biologics in the market. In addition, low manufacturing costs and the presence of highly skilled expertise at low costs are also factors that make Asia-Pacific a lucrative destination for the Biosimilars Market.

The factors restricting the growth of the market are high manufacturing complexities and costs, stringent regulatory environment in the U.S. and Europe, innovative strategies used by biologic drug manufacturers to protect th
'/>"/>

SOURCE MarketsandMarkets
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Immune Deficiency Foundation Urges FDA To Exempt Immunoglobulin From Biosimilars Pathway
2. Despite Recession, Global Biosimilars Market Grew Over 40% 2010-2011, Set to Reach $3.6 Billion by 2016
3. Biosimilars: Global Markets
4. UBM Conferences Unveils Details for Upcoming Generics and Biosimilars Conference
5. FDA New Guidelines for Biosimilars and Biobetters: An Outlook for 2013
6. Biosimilars Market Expected to Soar
7. Viropro and Oncobiologics Sign Emerging Markets Biosimilars Deal
8. XBiotech Expands Portfolio to Include Biosimilars
9. Recall of Anemia Drug Omontys Rings Alarm Over Biosimilars
10. Seminar Spotlights Key Trends in Biologics and Biosimilars
11. Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... 2014 Local veterinary surgeon, Dr. Tim ... study of donor stem cells for dogs with osteoarthritis. ... and has performed clinical stem cell therapy for 7 ... determine if a single injection of donor stem cells ... reduce pain and inflammation in the treated joints. ...
(Date:10/19/2014)... -- NextCODE Health, which enables clinicians and researchers to use ... announced the launch of its new genomic data analysis and ... Society of Human Genetics (ASHG) annual meeting in ... apply for free beta access, visit www.nextcode.com . A ... viewed here . The Exchange: ...
(Date:10/19/2014)... The Asia-Pacific Speech Analytics market report defines and ... and forecast of revenue. This market is estimated to ... by 2019, at a Compound Annual Growth Rate (CAGR) ... the TOC of the Asia-Pacific Speech Analytics market report ... It also provides a glimpse of the segmentation in ...
(Date:10/19/2014)... 2014 The report "Unmanned Ground ... Security), Technology, Payload, Type & by Geography - ... global unmanned ground vehicle market into various sub ... market sizes. The report also identifies the factors ... it along with the adoption trends. , The ...
Breaking Biology Technology:Cascade Veterinary Referral Center Seeks Candidates for an Investigational Study of Stem Cells for Dogs with Arthritis 2The NextCODE Exchange: The first global, real-time system for sharing full-resolution genomic data 2The NextCODE Exchange: The first global, real-time system for sharing full-resolution genomic data 3The Asia-Pacific Speech Analytics market is estimated to reach $208 million by 2019 - New Report by MicroMarket Monitor 2The Asia-Pacific Speech Analytics market is estimated to reach $208 million by 2019 - New Report by MicroMarket Monitor 3The Asia-Pacific Speech Analytics market is estimated to reach $208 million by 2019 - New Report by MicroMarket Monitor 4Unmanned Ground Vehicle (UGV) Market Estimated to Reach $8.26 Billion by 2020 - New Research Report by MarketsandMarkets 2Unmanned Ground Vehicle (UGV) Market Estimated to Reach $8.26 Billion by 2020 - New Research Report by MarketsandMarkets 3Unmanned Ground Vehicle (UGV) Market Estimated to Reach $8.26 Billion by 2020 - New Research Report by MarketsandMarkets 4Unmanned Ground Vehicle (UGV) Market Estimated to Reach $8.26 Billion by 2020 - New Research Report by MarketsandMarkets 5
... ... ... ... SEATTLE , March 23 /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq: ONTY ) today announced that Merck Serono, a division of Merck KGaA of ...
... Inc., and the University of Massachusetts Amherst announced today that the U.S. Patent and ... Related Materials" describing the novel creation of products, including biofuels, through the fermentation of biomass by ... ... ...
... ... lead Brooks Instrument’s customer service and order entry teams with a major focus on integrating ... organization. Dunn will report to Steve Fierce, Brooks Instrument Vice President of Sales. , ... Hatfield, PA (Vocus) March 23, 2010 ...
Cached Biology Technology:Oncothyreon announces temporary suspension of Stimuvax clinical trials by Merck Serono 2Oncothyreon announces temporary suspension of Stimuvax clinical trials by Merck Serono 3Oncothyreon announces temporary suspension of Stimuvax clinical trials by Merck Serono 4Oncothyreon announces temporary suspension of Stimuvax clinical trials by Merck Serono 5Oncothyreon announces temporary suspension of Stimuvax clinical trials by Merck Serono 6Qteros and UMass Amherst Announce the Issuance of a U.S. Patent for Production of Ethanol From a Unique Microorganism, the Q Microbe(TM) 2Qteros and UMass Amherst Announce the Issuance of a U.S. Patent for Production of Ethanol From a Unique Microorganism, the Q Microbe(TM) 3Qteros and UMass Amherst Announce the Issuance of a U.S. Patent for Production of Ethanol From a Unique Microorganism, the Q Microbe(TM) 4Qteros and UMass Amherst Announce the Issuance of a U.S. Patent for Production of Ethanol From a Unique Microorganism, the Q Microbe(TM) 5Qteros and UMass Amherst Announce the Issuance of a U.S. Patent for Production of Ethanol From a Unique Microorganism, the Q Microbe(TM) 6Daniel Dunn Joins Brooks Instrument as Director of Customer Service 2
(Date:10/16/2014)... causes severe respiratory tract infections and worldwide claims ... at VIB and Ghent University have succeeded in ... common virus infection. , Xavier Saelens (VIB/UGent): ... the way for the development of a novel ... causes suffering in numerous small children and elderly ...
(Date:10/15/2014)... a non-traditional biophysics textbook and it describes how life ... of discovery into biological systems and provides an understanding ... is about how our genes make proteins that control ... cells in an organism. It quantifies the principles of ... be found on both large and small scales. The ...
(Date:10/15/2014)... Fred Alt will be awarded the 44th Rosenstiel Award ... for his pioneering research exploring the mechanisms of genomic ... cancer cells. Alt is the second alumnus to win ... Nobel Prize in 2003. , Alt is the Charles ... at Harvard Medical School and an investigator at the ...
Breaking Biology News(10 mins):New perspectives for development of an RSV vaccine 2New book about life as seen from physics 2Brandeis awards 44th Rosenstiel Award to pioneering geneticist Fred Alt 2
... Researchers at the Whitehead Institute and Memorial Sloan-Kettering Cancer ... yeast Argonaute protein bound to RNA. This complex plays a ... gene expression. Describing the molecular structure of a eukaryotic Argonaute ... close to a decade. "You can learn a lot ...
... cotton bollworm to insect-killing cotton plants involves more diverse ... in the journal Proceedings of the National Academy ... insecticides, which can harm animals other than the target ... produce toxins derived from the bacterium Bacillus thuringiensis ...
... graduate student has developed a novel means for charting ... Katy Richards-Hrdlicka, a doctoral candidate at the Yale ... amphibians for the presence of Batrachochytrium dendrobatidis , ... extinction. The pathogen is found on every continent inhabited ...
Cached Biology News:Structure of RNAi complex now crystal clear 2Trouble on the horizon for GM crops? 2Trouble on the horizon for GM crops? 3Trouble on the horizon for GM crops? 4Preserved frogs hold clues to deadly pathogen 2
... determinations for petroleum-based applications. Multiple solvents can be used, such as water, benzene, formamide, nitrobenzene, ... ... ... ...
Fast, sensitive quantitation of total MEK 1/2 concentration....
... ultimate in utility and flexibility press-to-seal silicone ... needs of the researcher. They are available ... as sheet material that can be easily ... are autoclavable and non-cytotoxic and can be ...
... High Sensitivity Laboratory Osmometer for 50 L samples. Operating head automatically rises at the end of determination; ... ... ... ...
Biology Products: